318.15M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Similar securities

Based on sector and market capitalization

Report issue